• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic updates 2011 battery warning on Synchromed II implantable drug pumps

April 19, 2017 By Brad Perriello

Medtronic's SynchroMedMedtronic (NYSE:MDT) this month updated physicians on a warning it 1st issued in July 2011 about the batteries in its SynchroMed II implantable drug infusion pump.

The pumps are used primarily to treat chronic pain or severe spinal or cerebral spasticity. The issue, 1st reported in July 2009, relates to the formation of a filmy substance within the pump battery that can lead the device to shut down suddenly, causing a patient’s pain and symptoms to return or triggering withdrawal symptoms. Returned product analysis proved the failed devices’ alarms functioned as designed, Fridley, Minn.-based Medtronic said at the time.

There were 55 confirmed cases of the devices failing as of May 32, 2011, Medtronic said back then, including 1 death attributed to baclofen withdrawal syndrome.

In a letter dated April 2017 sent to European doctors, Medtronic updated the numbers for pumps with batteries made from March 2005 through December 2010. The company said there was a 0.13% cumulative probability for pump failure at 72 months due to the issue.

“This rate remains within the failure rate upper bound of 0.2% that was reported in 2011,” the company said.

For pumps with batteries made between January 2011 through June 2011 there was a 3.17% cumulative probability of failure due to the issue, Medtronic said, which exceeds the 2011 upper bound limit.

Prophylactic replacement of SynchroMed II pumps is not recommended “because of the estimated low occurrence rates, the presence of pump alarms, and the risks associated with replacement surgery,” the company said. But if low battery reset, premature elective replacement indicator or end of service alarms occur, replacement surgery should be set up “as soon as possible,” according to the letter.

The SynchroMed II and SynchroMed EL pumps were recalled in 2013 because they unintentionally delivered drugs during the priming bolus procedure and patients were at risk for overinfusion in the cerebrospinal fluid followed by a period of reduced drug delivery. As of July 5, 2016, there were 103 incidents of overinfusion among the more than 238,000 SynchroMed II pumps implanted since the device came to market (0.04%).

Filed Under: Drug-Device Combinations, Featured, Neurological, Pain Management, Recalls, Wall Street Beat Tagged With: Medtronic

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS